<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Etiology and clinical manifestations of renal tubular acidosis in infants and children</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Etiology and clinical manifestations of renal tubular acidosis in infants and children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Etiology and clinical manifestations of renal tubular acidosis in infants and children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tej K Mattoo, MD, DCH, FRCP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">F Bruder Stapleton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 02, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>In children, renal tubular acidosis (RTA) is due to either an inherited or acquired defect that affects the kidney's ability to absorb filtered bicarbonate, or excrete ammonia or titratable acid. RTA is characterized by a normal anion gap (hyperchloremic) metabolic acidosis caused by the net retention of hydrogen or loss of bicarbonate.</p><p>The most common pediatric forms of RTA are distal (type 1) and proximal (type 2)  (<a class="graphic graphic_table graphicRef58428" href="/z/d/graphic/58428.html" rel="external">table 1</a>). The two other types of RTA are mixed (type 3) and hypoaldosteronism (type 4)</p><p>The etiology and clinical manifestations of the different forms of RTA in infants and children will be reviewed here.</p><p>Other topics review the following aspects of RTA:</p><p class="bulletIndent1"><span class="glyph">●</span>Diagnosis (see  <a class="medical medical_review" href="/z/d/html/2328.html" rel="external">"Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis"</a> and  <a class="medical medical_review" href="/z/d/html/2377.html" rel="external">"Causes and evaluation of hyperkalemia in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pathophysiology (see  <a class="medical medical_review" href="/z/d/html/2327.html" rel="external">"Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Treatment (see  <a class="medical medical_review" href="/z/d/html/2329.html" rel="external">"Treatment of distal (type 1) and proximal (type 2) renal tubular acidosis"</a> and  <a class="medical medical_review" href="/z/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)"</a>)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">DISTAL (TYPE 1) RENAL TUBULAR ACIDOSIS</span></p><p class="headingAnchor" id="H1133597864"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>Type 1 (distal) RTA is due to impaired distal acid secretion that results in an inability to excrete the daily acid load. In the absence of alkali therapy, progressive hydrogen ion retention leads to a fall in plasma bicarbonate concentration that is accompanied by an abnormally high urine pH (greater than 5.5)  (<a class="graphic graphic_table graphicRef58428" href="/z/d/graphic/58428.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H3"><span class="h2">Etiology</span><span class="headingEndMark"> — </span>The etiology of distal RTA in children can be divided into genetic and acquired disorders  (<a class="graphic graphic_table graphicRef56437" href="/z/d/graphic/56437.html" rel="external">table 2</a>).</p><p class="headingAnchor" id="H4"><span class="h3">Genetic causes</span><span class="headingEndMark"> — </span>Genetic primary causes of distal RTA include mutations of genes that directly affect membrane transport proteins such as the chloride-bicarbonate exchanger (AE1) or subunits of the H-ATPase pump  (<a class="graphic graphic_table graphicRef59008" href="/z/d/graphic/59008.html" rel="external">table 3</a>) and others that indirectly affect intracellular trafficking [<a href="#rid1">1-3</a>]. (See  <a class="medical medical_review" href="/z/d/html/2327.html" rel="external">"Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dominant distal RTA</strong> – Mutations of the <em>SLC4A1</em> gene (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F179800%3Fsearch%3Ddistal+rta%26highlight%3Ddistal+rta&amp;token=87jLzclRwWxNoI%2BQq5Gg7%2FS2MtW7DsR4UVDGQjU01hPKKF%2FM%2BF3xdSRauyxv1Bng7q4WnA2rMitDBxoH8CTLhTutylEG8HayQrvuaAu0spA%3D&amp;TOPIC_ID=6121" target="_blank">MIM# 179800</a>), located on chromosome 17q21-q22, which encodes the chloride-bicarbonate exchanger (AE1 or band 3), have been described in several families with autosomal dominant distal RTA [<a href="#rid4">4-7</a>]. Patients with dominant distal RTA generally have milder acidosis than those with recessive disease and present later in life, often in adolescence or adulthood [<a href="#rid8">8</a>]. Untreated patients have metabolic acidosis that is associated with hypercalciuria, nephrolithiasis or nephrocalcinosis, osteomalacia, and erythrocytosis. Mutations of the <em>SLC4A1</em> gene also are reported in some patients with hereditary spherocytosis and Southeast Asian ovalocytosis, both of which can be associated with RTA. (See  <a class="medical medical_review" href="/z/d/html/7079.html" rel="external">"Hereditary spherocytosis"</a> and  <a class="medical medical_review" href="/z/d/html/142822.html" rel="external">"Southeast Asian ovalocytosis (SAO)", section on 'Specific SLC4A1 deletion'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recessive distal RTA with deafness</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with mutations in the gene <em>ATP6V1B1</em> (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F192132%3Fsearch%3Ddistal+rta%26highlight%3Ddistal+rta&amp;token=87jLzclRwWxNoI%2BQq5Gg7xJ1QQ%2BPHfn%2FD%2BrI3BAPKhfKKF%2FM%2BF3xdSRauyxv1BngYBTmuEV%2BaHNXwxZExQMY%2FMwWWH3bASuIe3sDHxBv0Z4%3D&amp;TOPIC_ID=6121" target="_blank">MIM# 192132</a>), which encodes the B1 subunit of H-ATPase, have distal RTA and sensorineural deafness [<a href="#rid9">9,10</a>]. This gene is expressed in the intercalated cells of the distal renal tubule, cochlea, and male genital tract, and is located on chromosome 2p13 [<a href="#rid9">9-12</a>]. Untreated patients develop severe metabolic acidosis with poor growth, rickets, and nephrocalcinosis during infancy and early childhood. Patients also may develop progressive bilateral sensorineural hearing loss (SNHL) that typically begins in infancy [<a href="#rid13">13</a>]. Treatment of acidosis prevents poor growth, rickets, and nephrocalcinosis but does not improve or prevent ongoing hearing loss.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Missense mutations in the gene <em>FOXI1</em> (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F601093%3Fsearch%3DFOXI1%26highlight%3Dfoxi1&amp;token=87jLzclRwWxNoI%2BQq5Gg7wnXFITbPk7qh7IvkgvEoBrlHaJhv6QpQxwrAVoTxWaapx06wGNgoVe9EZVQLW1Xga8AtSQsFLDSFqHlsS1NKKs%3D&amp;TOPIC_ID=6121" target="_blank">MIM# 601093</a>), which encodes the transcription factor FOXI1, have been reported in two consanguineous kindreds with autosomal recessive distal RTA and sensorineural deafness [<a href="#rid14">14</a>]. Affected individuals also had nephrocalcinosis and developed medullary cysts. In animal models, FOXI1 is a transcription factor that regulates expression of B1 and a4 subunits of the V-ATPase proton pump and the anion-exchange proteins AE1, AE4, and pendrin in the intercalated cells of the renal tubules and the endolymphatic duct and sac of the inner ear.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recessive distal RTA without deafness</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with mutations in the gene <em>ATP6V0A4</em> (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F605239%3Fsearch%3DATP6V0A4%26highlight%3Datp6v0a4&amp;token=87jLzclRwWxNoI%2BQq5Gg70R%2BKYQW4lxKnbdF0MS9vCyCfW%2B8VdjA5h6oxAMOB%2B5c0VPHECFS7yxZWV0i1pHosx%2FKFwDHjX%2Fw2n%2FqLOpEr9A%3D&amp;TOPIC_ID=6121" target="_blank">MIM# 605239</a>), located on chromosome 7q33-q34, which encodes the a4 subunit of H-ATPase, develop distal RTA without early hearing loss [<a href="#rid15">15</a>]. The severity of metabolic acidosis and its associated findings of failure to thrive, rickets, and nephrocalcinosis are similar to that seen in patients with mutations that affect the B1 subunit. This gene product is also expressed in the inner ear, although most children with <em>ATP6V0A4</em> gene mutations have normal hearing based upon audiometric screening, there are cases with sensorineural hearing loss (SNHL) [<a href="#rid2">2,16</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a report from Southeast Asia, a family with recessively transmitted distal RTA was associated with homozygosity for three mutations in <em>SLC4AE1</em> [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In another report, mutations in the gene <em>WDR72</em> have been reported in two families with recessive distal RTA. The product of <em>WDR72</em> is thought to be involved with endocytic vesicle trafficking [<a href="#rid18">18</a>]. Mutations of <em>WDR72</em> have previously been identified as a cause of amelogenesis imperfecta (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F613214&amp;token=87jLzclRwWxNoI%2BQq5Gg7%2Fc5E%2FXf7uxO2%2FJ98mh0gsuZDbuqHByUd4dQ%2FFLG9KNd&amp;TOPIC_ID=6121" target="_blank">MIM # 613214</a>) that affect tooth enamel formation. One of the individuals in this report had distal RTA and tooth enamel hypoplasia.</p><p></p><p class="headingAnchor" id="H5"><span class="h3">Acquired causes</span><span class="headingEndMark"> — </span>The acquired causes of distal RTA in children include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medications</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The administration of amphotericin B can result in reversible distal RTA. However, the use of lipid formulations of amphotericin B avoids tubular damage and RTA. (See  <a class="medical medical_review" href="/z/d/html/2364.html" rel="external">"Amphotericin B nephrotoxicity", section on 'Electrolyte and acid-base disorders'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_pediatric" data-topicid="12559" href="/z/d/drug information/12559.html" rel="external">Lithium</a> can cause an incomplete distal RTA with impairment of urine acidification but typically does not cause metabolic acidosis. (See  <a class="medical medical_review" href="/z/d/html/2358.html" rel="external">"Renal toxicity of lithium", section on 'Renal tubular acidosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Autoimmune disorders</strong> – Although rare in children, reported autoimmune conditions associated with distal RTA include Sjögren's disease [<a href="#rid19">19</a>] and systemic lupus erythematosus [<a href="#rid20">20,21</a>]. (See  <a class="medical medical_review" href="/z/d/html/7187.html" rel="external">"Kidney disease in primary Sjögren's disease", section on 'Distal renal tubular acidosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obstructive uropathy</strong> – Distal RTA with hyperkalemia may be present in patients with obstructive uropathy. It is caused by mineralocorticoid resistance with impaired distal Na resorption and loss of the lumen-negative potential difference due to reduced activities of transporter proteins, such as apical Na/K/2Cl cotransporters, sodium channels, and basolateral Na-K-ATPase. (See  <a class="medical medical_review" href="/z/d/html/2327.html" rel="external">"Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance"</a>.)</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>The clinical manifestations of distal RTA vary depending upon the underlying etiology. The recessive genetic forms present in infancy, the dominant form later in life, and acquired distal RTA may occur at any age based upon the timing of renal tubular injury.</p><p class="headingAnchor" id="H7"><span class="h3">Recessive form</span><span class="headingEndMark"> — </span>As discussed previously, the recessive genetic form of RTA usually presents during infancy and generally is associated with severe clinical manifestations [<a href="#rid2">2,22</a>]. These findings include:</p><p class="bulletIndent1"><span class="glyph">●</span>Severe hyperchloremic metabolic acidosis (serum bicarbonate levels may decrease below 10 mEq/L)</p><p class="bulletIndent1"><span class="glyph">●</span>Moderate to severe hypokalemia (serum potassium ≤ 3.0 mEq/L)</p><p class="bulletIndent1"><span class="glyph">●</span>Nephrocalcinosis</p><p class="bulletIndent1"><span class="glyph">●</span>Vomiting</p><p class="bulletIndent1"><span class="glyph">●</span>Dehydration</p><p class="bulletIndent1"><span class="glyph">●</span>Poor growth</p><p class="bulletIndent1"><span class="glyph">●</span>Rickets</p><p class="bulletIndent1"><span class="glyph">●</span>Bilateral SNHL in some cases with mutations of the gene that encodes B1 subunit of the H-ATPase pump (see <a class="local">'Genetic causes'</a> above)</p><p></p><p class="headingAnchor" id="H8"><span class="h3">Dominant form</span><span class="headingEndMark"> — </span>In comparison with recessive distal RTA, dominant distal RTA is usually associated with milder disease, and presents later in life (often in adolescence and adulthood) [<a href="#rid8">8</a>]. The most common initial finding is renal stone or nephrocalcinosis. Patients typically have mild or no acidosis (referred to as incomplete RTA), mild to moderate hypokalemia, and less commonly, poor growth [<a href="#rid2">2,4,22</a>]. Bone disease is a rare finding. (See  <a class="medical medical_review" href="/z/d/html/2328.html" rel="external">"Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis", section on 'Incomplete distal RTA'</a>.)</p><p class="headingAnchor" id="H1355765948"><span class="h3">Chronic kidney disease</span><span class="headingEndMark"> — </span>Chronic kidney disease (CKD) with a glomerular filtration rate of &lt;90 cc/min per 1.73 m<sup>2</sup>, has been reported as a complication of hereditary distal RTA [<a href="#rid2">2</a>]. CKD presents after the pubertal growth spurt and is thought to be due to the combination of nephrocalcinosis, persistent hypokalemia, and repeated episodes of hypovolemia that results in progressive tubulointerstitial injury. In a retrospective long-term study of 16 patients, the prevalence of CKD at 20- and 40-year follow-up in patients was 41 and 71 percent, respectively [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H9"><span class="h1">PROXIMAL (TYPE 2) RENAL TUBULAR ACIDOSIS</span></p><p class="headingAnchor" id="H3635342127"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>Proximal RTA is caused by a reduction in proximal bicarbonate reabsorptive capacity resulting in a fall in the plasma bicarbonate. Depending on the renal bicarbonate excretion threshold and serum bicarbonate level, urine pH may be inappropriately high or normal. (See  <a class="medical medical_review" href="/z/d/html/2327.html" rel="external">"Overview and pathophysiology of renal tubular acidosis and the effect on potassium balance", section on 'Proximal (type 2) RTA'</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Etiology</span><span class="headingEndMark"> — </span>Proximal RTA may present either as an isolated tubular defect or as a component of a generalized proximal tubular disorder called the Fanconi syndrome  (<a class="graphic graphic_table graphicRef68165" href="/z/d/graphic/68165.html" rel="external">table 4</a>).</p><p class="headingAnchor" id="H11"><span class="h3">Isolated proximal renal tubular acidosis</span><span class="headingEndMark"> — </span>In children, isolated proximal RTA is less common. It is usually due to a transient or inherited  (<a class="graphic graphic_table graphicRef59008" href="/z/d/graphic/59008.html" rel="external">table 3</a>) disorder.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transient or sporadic proximal RTA</strong> – Infants with transient or sporadic proximal RTA have a decreased capacity to bind bicarbonate without any identifiable cause or evidence of renal abnormality. These infants who are beyond the newborn period are believed to have extended functional immaturity of the proximal sodium-hydrogen exchanger (or antiporter), resulting in an age-based decrease in bicarbonate reabsorption capacity. This reduced capacity, which is the same as that of a normal neonate, results in a persistently low serum bicarbonate level [<a href="#rid24">24</a>]. Patients usually present within the first year of life with symptoms of tachypnea, growth failure, recurrent vomiting, and feeding difficulties [<a href="#rid25">25,26</a>]. Bone disease, hypokalemia, and urinary concentration defects are uncommon, and hypercalciuria, nephrocalcinosis, and urolithiasis do not occur. Resolution of symptoms and a rapid increase in growth are seen with alkali therapy, which can be discontinued after several years without recurrence of RTA and its symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Autosomal recessive proximal RTA</strong> – Mutations in the gene <em>SLC4A4</em>, which encodes the <a class="drug drug_pediatric" data-topicid="12795" href="/z/d/drug information/12795.html" rel="external">sodium bicarbonate</a> cotransporter (NBC), are associated with isolated proximal RTA [<a href="#rid27">27-29</a>]. This rare disorder with reported cases from Europe and Japan presents with:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severe hypokalemic.</p><p class="bulletIndent2"><span class="glyph">•</span>Hyperchloremic metabolic acidosis.</p><p class="bulletIndent2"><span class="glyph">•</span>Growth retardation.</p><p class="bulletIndent2"><span class="glyph">•</span>Ocular abnormalities including glaucoma, cataracts, and band keratopathy. Ocular findings may progress with age [<a href="#rid28">28,30</a>].</p><p class="bulletIndent2"><span class="glyph">•</span>Additional features include enamel defects of the permanent teeth, impaired psychomotor and cognitive function, and opacification of the basal ganglia [<a href="#rid31">31,32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Autosomal dominant proximal RTA</strong> – Case reports have described a rare autosomal dominant inheritance pattern of proximal RTA in two families with several affected members [<a href="#rid33">33,34</a>]. In both these families, clinical manifestations were limited to short stature and metabolic acidosis. There was no evidence of bone disease or hypercalciuria. No mutation was found in any of the nine tested candidate genes studied in the Israeli pedigree [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1">Studies using a knockout mouse model identified the gene <em>SLC9A3</em> as a candidate gene for dominant proximal RTA [<a href="#rid35">35</a>]. It encodes one of the five plasma membrane sodium-hydrogen exchangers.</p><p></p><p class="headingAnchor" id="H12"><span class="h3">Fanconi syndrome</span><span class="headingEndMark"> — </span>Generalized proximal tubular dysfunction, referred to as Fanconi syndrome, is characterized by proximal RTA, phosphaturia, renal glucosuria (with a normal plasma glucose concentration), aminoaciduria, and tubular proteinuria.</p><p class="headingAnchor" id="H3115079733"><span class="h4">Etiology</span><span class="headingEndMark"> — </span>The etiology of Fanconi syndrome includes inherited diseases or acquired causes:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetic conditions</strong> associated with Fanconi syndrome include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Dent disease (see  <a class="medical medical_review" href="/z/d/html/7363.html" rel="external">"Dent disease (X-linked recessive nephrolithiasis)", section on 'Proximal tubular reabsorptive failure and proteinuria'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cystinosis (see  <a class="medical medical_review" href="/z/d/html/6139.html" rel="external">"Cystinosis", section on 'Renal manifestations'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Tyrosinemia type 1 (see  <a class="medical medical_review" href="/z/d/html/2935.html" rel="external">"Disorders of tyrosine metabolism", section on 'Hereditary tyrosinemia type 1'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Galactosemia (see  <a class="medical medical_review" href="/z/d/html/2928.html" rel="external">"Galactosemia: Clinical features and diagnosis", section on 'Clinical features'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Wilson disease (see  <a class="medical medical_review" href="/z/d/html/83837.html" rel="external">"Wilson disease: Clinical manifestations, diagnosis, and natural history", section on 'Other organs'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lowe oculocerebrorenal syndrome (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F309000&amp;token=tEpDslnpc0F0kICl%2Fz7sFc1ZyERnYUPWku4Em4XflYznmDiqarhXl8DJnVqmWv%2By&amp;TOPIC_ID=6121" target="_blank">MIM #309000</a>), also referred to as Lowe syndrome (see  <a class="medical medical_review" href="/z/d/html/7363.html" rel="external">"Dent disease (X-linked recessive nephrolithiasis)", section on 'Dent disease 2 versus Lowe syndrome'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hereditary fructose intolerance</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mitochondrial myopathies </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acquired causes</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Drugs – Medication associated with Fanconi syndrome include aminoglycosides, <a class="drug drug_pediatric" data-topicid="13162" href="/z/d/drug information/13162.html" rel="external">cisplatin</a>, <a class="drug drug_pediatric" data-topicid="13373" href="/z/d/drug information/13373.html" rel="external">ifosfamide</a>, <a class="drug drug_pediatric" data-topicid="12873" href="/z/d/drug information/12873.html" rel="external">valproic acid</a>, and <a class="drug drug_pediatric" data-topicid="13104" href="/z/d/drug information/13104.html" rel="external">deferasirox</a> [<a href="#rid36">36-38</a>] (see  <a class="medical medical_review" href="/z/d/html/7214.html" rel="external">"Manifestations of and risk factors for aminoglycoside nephrotoxicity", section on 'Electrolyte abnormalities'</a> and  <a class="medical medical_review" href="/z/d/html/2383.html" rel="external">"Ifosfamide nephrotoxicity", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/7231.html" rel="external">"Cisplatin nephrotoxicity", section on 'Fanconi-like syndrome'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Heavy metals – Heavy metals associated with Fanconi syndrome include lead, mercury, and cadmium (see  <a class="medical medical_review" href="/z/d/html/7180.html" rel="external">"Lead nephropathy and lead-related nephrotoxicity", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/7202.html" rel="external">"Epidemiology and toxicity of cadmium", section on 'Kidney disease'</a> and  <a class="medical medical_review" href="/z/d/html/7179.html" rel="external">"Mercury toxicity", section on 'Tubular dysfunction'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Vitamin D disorders – In patients with vitamin D deficiency or vitamin D resistance rickets, type 2 RTA can occur because of secondary hyperparathyroidism caused by chronic hypocalcemia</p><p></p><p class="headingAnchor" id="H1330793022"><span class="h4">Clinical manifestations</span><span class="headingEndMark"> — </span>In children, the most common clinical findings of Fanconi syndrome are growth failure, and episodes of hypovolemia due to polyuria caused by impaired concentrating ability. Poor growth may be due to hypophosphatemia, persistent acidosis, chronic hypokalemia, rickets, and volume depletion [<a href="#rid39">39</a>]. Other findings may include bony abnormalities, including rickets and osteomalacia due to hypophosphatemia and low levels of calcitriol (1,25 dihydroxy vitamin D), and constipation and muscle weakness caused by significant hypokalemia (serum potassium less than 3 mEq/L). (See  <a class="medical medical_review" href="/z/d/html/2297.html" rel="external">"Clinical manifestations and treatment of hypokalemia in adults", section on 'Severe muscle weakness or rhabdomyolysis'</a>.)</p><p>Laboratory evaluation demonstrates hyperchloremic metabolic acidosis, hypophosphatemia, moderate to severe hypokalemia (serum potassium levels less than 3 mEq/L), and proteinuria.</p><p class="bulletIndent1">The age of presentation varies with the underlying etiology.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Genetic causes</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Infancy – Several genetic causes of Fanconi appear during infancy, including Lowe oculocerebrorenal syndrome, the infantile form of cystinosis, and Dent disease. (See  <a class="medical medical_review" href="/z/d/html/7363.html" rel="external">"Dent disease (X-linked recessive nephrolithiasis)", section on 'Proximal tubular reabsorptive failure and proteinuria'</a> and  <a class="medical medical_review" href="/z/d/html/6139.html" rel="external">"Cystinosis", section on 'Infantile form'</a> and  <a class="medical medical_review" href="/z/d/html/7363.html" rel="external">"Dent disease (X-linked recessive nephrolithiasis)", section on 'Dent disease 2 versus Lowe syndrome'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Childhood and adolescence – Other genetic conditions, such as Wilson disease, late-onset forms of cystinosis, and galactosemia present with Fanconi syndrome later in life as accumulation of toxic material (eg, copper in Wilson disease) over time results in progressive proximal renal tubular damage. (See  <a class="medical medical_review" href="/z/d/html/2928.html" rel="external">"Galactosemia: Clinical features and diagnosis", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/z/d/html/6139.html" rel="external">"Cystinosis", section on 'Late-onset (juvenile) cystinosis'</a> and  <a class="medical medical_review" href="/z/d/html/83837.html" rel="external">"Wilson disease: Clinical manifestations, diagnosis, and natural history", section on 'Other organs'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acquired Fanconi may occur at any age depending upon the timing of exposure to noxious toxins and drugs, which injure the proximal tubule.</p><p></p><p class="headingAnchor" id="H15"><span class="h1">MIXED (TYPE 3) RENAL TUBULAR ACIDOSIS</span><span class="headingEndMark"> — </span>Type 3 RTA, also referred to as mixed RTA, is a rare autosomal recessive disorder that affects mostly children of Arab, North African, and Middle Eastern descent. Patients have features of both distal and proximal RTA. These include a high fractional excretion of bicarbonate and increased urine citrate, which occur in type 2 RTA, in addition to the features of type 1 RTA, such as inappropriately high urine pH in presence of non-anion gap metabolic acidosis, positive urine anion gap, and a low urine-blood PCO<sub>2</sub> after urine alkalization with intravenous <a class="drug drug_pediatric" data-topicid="12795" href="/z/d/drug information/12795.html" rel="external">sodium bicarbonate</a> or <a class="drug drug_pediatric" data-topicid="13213" href="/z/d/drug information/13213.html" rel="external">acetazolamide</a>. It is due to an inherited carbonic anhydrase (CA) 2 deficiency.</p><p>Because <em>CA2</em> is widely expressed, mutations of the <em>CA2</em> gene (located on chromosome 8q22) result in a syndrome with multiple clinical findings, including mixed RTA, osteopetrosis, cerebral calcification, and intellectual disability [<a href="#rid40">40-43</a>]. This constellation of findings is also referred to as Guibaud-Vainsel syndrome or marble brain disease. Other clinical features include bone fractures (due to increased bone fragility) and growth failure [<a href="#rid44">44</a>]. Excessive facial bone growth leads to facial dysmorphism, and conductive hearing loss and blindness due to nerve compression. The majority of affected patients are of Arabic descent and live in North Africa and the Middle East.</p><p>In some patients with type 1 RTA, increased parathyroid hormone secretion due to hypocalcemia may induce bicarbonaturia in the proximal tubule mimicking type 3 RTA.</p><p>Based on the author's experience, patients with type 3 RTA generally require a lower dose of alkali to correct acidosis as compared with those with isolate type 2 RTA.</p><p class="headingAnchor" id="H16"><span class="h1">ALDOSTERONE DEFICIENCY OR RESISTANCE (TYPE 4 RENAL TUBULAR ACIDOSIS)</span><span class="headingEndMark"> — </span>Hypoaldosteronism primarily results in a loss of NH<sub>4</sub> excretion. It is uncommon in children and is usually due to either aldosterone deficiency or tubular resistance to the action of aldosterone, also called pseudohypoaldosteronism (ie, mineralocorticoid deficiency). Hypoaldosteronism is typically characterized mild acidosis (serum bicarbonate above 17 mEq/L) due to the impairment of NH<sub>4</sub> excretion. Normally during acidosis, increased levels of aldosterone stimulate renal acid excretion by enhancing ammonia (NH<sub>4</sub>) excretion and increasing H<sup>+ </sup>excretion either directly or indirectly by a voltage-dependent mechanism linked to increased sodium reabsorption. Hyperkalemia is also common because aldosterone is the major hormone that promotes potassium excretion. Other clinical features in children with hypoaldosteronism may include failure to thrive and hyponatremia because of sodium loss.</p><p>Unlike adults, in whom the most common causes for a lack of response to aldosterone are kidney damage due to diabetic nephropathy or chronic interstitial nephritis, hypoaldosteronism in children is more likely to be due to drugs that impair aldosterone release or function  (<a class="graphic graphic_table graphicRef82440" href="/z/d/graphic/82440.html" rel="external">table 5</a>). These include heparin, nonsteroidal antiinflammatory agents, angiotensin inhibitors, <a class="drug drug_pediatric" data-topicid="12865" href="/z/d/drug information/12865.html" rel="external">trimethoprim</a>, calcineurin inhibitors (<a class="drug drug_pediatric" data-topicid="13193" href="/z/d/drug information/13193.html" rel="external">cyclosporine</a> and <a class="drug drug_pediatric" data-topicid="12822" href="/z/d/drug information/12822.html" rel="external">tacrolimus</a>), and potassium sparing diuretics (eg, <a class="drug drug_pediatric" data-topicid="12803" href="/z/d/drug information/12803.html" rel="external">spironolactone</a>). In addition, human immunodeficiency virus (HIV) infection is also associated with hypoaldosteronism [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/z/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)", section on 'Etiology'</a>.)</p><p>In children, hypoaldosteronism due to inherited disorders include the following rare disorders, which are discussed in greater detail separately (see  <a class="medical medical_review" href="/z/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)", section on 'Etiology'</a> and  <a class="medical medical_review" href="/z/d/html/5813.html" rel="external">"Causes of primary adrenal insufficiency in children", section on 'Disorders of steroidogenesis'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Congenital adrenal insufficiency</p><p class="bulletIndent1"><span class="glyph">●</span>Aldosterone synthase deficiency</p><p class="bulletIndent1"><span class="glyph">●</span>Pseudohypoaldosteronism distal and 2 (also known as Gordon syndrome)</p><p></p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Introduction</strong> – Renal tubular acidosis (RTA) is due to either an inherited or acquired renal tubular defect that affects the kidney's ability to absorb filtered bicarbonate, or excrete ammonia or titratable acid. It is characterized by a normal anion gap (hyperchloremic) metabolic acidosis caused by the net retention of hydrogen or the net loss of bicarbonate. There are several subgroups of RTA that include many genetic disorders  (<a class="graphic graphic_table graphicRef58428" href="/z/d/graphic/58428.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef59008" href="/z/d/graphic/59008.html" rel="external">table 3</a>). The most common pediatric forms are distal (type 1) RTA and proximal (type 2) RTA  (<a class="graphic graphic_table graphicRef58428" href="/z/d/graphic/58428.html" rel="external">table 1</a>). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Distal RTA</strong> – Distal (type 1) RTA is due to impaired distal acid secretion that results in an inability to excrete the daily acid load. It is divided into genetic causes due to mutations of genes that encode the chloride-bicarbonate exchanger (AE1) or subunits of the H-ATPase pump, and acquired causes due to distal tubular injury from drugs, autoimmune disorders, or obstructive uropathy. (See <a class="local">'Pathogenesis'</a> above and <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1">Clinical manifestations of distal RTA are dependent upon the underlying etiology  (<a class="graphic graphic_table graphicRef56437" href="/z/d/graphic/56437.html" rel="external">table 2</a>). Recessive autosomal distal RTA due to several different gene variants generally presents in infancy and is associated with more severe disease than the dominant form, which presents later in life  (<a class="graphic graphic_table graphicRef59008" href="/z/d/graphic/59008.html" rel="external">table 3</a>). (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Proximal RTA</strong> – Proximal (type 2) RTA is caused by a reduction in proximal renal tubular bicarbonate reabsorptive capacity, resulting in a fall in the plasma bicarbonate. Its etiology is divided into disorders with isolated RTA and those with generalized proximal tubular dysfunction, referred to as Fanconi syndrome. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Isolated proximal RTA – In children, isolated proximal RTA is rare and is usually due to an inherited or transient disorder. Clinical features vary with the underlying etiology. (See <a class="local">'Isolated proximal renal tubular acidosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fanconi syndrome – Fanconi syndrome is the most common cause of proximal RTA in children and is caused by inherited diseases (eg, Dent disease and cystinosis) and acquired disorders (eg, heavy metal toxicity and drugs). It is characterized by phosphaturia resulting in hypophosphatemia, renal glucosuria, aminoaciduria, tubular proteinuria, and proximal RTA. The age of clinical presentation depends upon the underlying etiology . Clinical findings include growth failure, hypovolemia, bony abnormalities (eg, rickets and osteomalacia), and constipation and muscle weakness due to hypokalemia. (See <a class="local">'Fanconi syndrome'</a> above and <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mixed RTA</strong> – Mixed (type 3) RTA is a rare autosomal recessive disorder that has features of both types 1 and 2 RTA. These include a high fractional excretion of bicarbonate and increased urine citrate, which occur in type 2 RTA, in addition to the features of type 1 RTA such as inappropriately high urine pH in presence of non-anion gap metabolic acidosis, positive urine anion gap, and a low urine-blood PCO<sub>2</sub> after urine alkalization. It is due to an inherited carbonic anhydrase (CA) 2 deficiency. (See <a class="local">'Mixed (type 3) renal tubular acidosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypoaldosteronism</strong> – Aldosterone deficiency or resistance (type 4 RTA) is due to either aldosterone deficiency or tubular resistance to the action of aldosterone. It is uncommon in children and is generally characterized by hyperkalemia and mild acidosis (serum bicarbonate above 17 mEq/L). In children, the most common cause of hypoaldosteronism is drugs (eg, heparin, nonsteroidal antiinflammatory agents, angiotensin inhibitors, <a class="drug drug_pediatric" data-topicid="12865" href="/z/d/drug information/12865.html" rel="external">trimethoprim</a>, calcineurin inhibitors, and potassium sparing diuretics) that impair aldosterone release or function. Human immunodeficiency virus (HIV) may also be associated with hypoaldosteronism. (See <a class="local">'Aldosterone deficiency or resistance (type 4 renal tubular acidosis)'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Besouw MTP, Bienias M, Walsh P, et al. Clinical and molecular aspects of distal renal tubular acidosis in children. Pediatr Nephrol 2017; 32:987.</a></li><li><a class="nounderline abstract_t">Palazzo V, Provenzano A, Becherucci F, et al. The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis. Kidney Int 2017; 91:1243.</a></li><li><a class="nounderline abstract_t">Lopez-Garcia SC, Emma F, Walsh SB, et al. Treatment and long-term outcome in primary distal renal tubular acidosis. Nephrol Dial Transplant 2019; 34:981.</a></li><li><a class="nounderline abstract_t">Bruce LJ, Cope DL, Jones GK, et al. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest 1997; 100:1693.</a></li><li><a class="nounderline abstract_t">Jarolim P, Shayakul C, Prabakaran D, et al. Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3- exchanger. J Biol Chem 1998; 273:6380.</a></li><li><a class="nounderline abstract_t">Karet FE, Gainza FJ, Györy AZ, et al. Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A 1998; 95:6337.</a></li><li><a class="nounderline abstract_t">Hu PY, Roth DE, Skaggs LA, et al. A splice junction mutation in intron 2 of the carbonic anhydrase II gene of osteopetrosis patients from Arabic countries. Hum Mutat 1992; 1:288.</a></li><li><a class="nounderline abstract_t">Alonso-Varela M, Gil-Peña H, Coto E, et al. Distal renal tubular acidosis. Clinical manifestations in patients with different underlying gene mutations. Pediatr Nephrol 2018; 33:1523.</a></li><li><a class="nounderline abstract_t">Royer P, Broyer M, Nordmann Y. [Enzymatic anomalies and human nephropathies]. Pathol Biol 1967; 15:803.</a></li><li><a class="nounderline abstract_t">Karet FE, Finberg KE, Nelson RD, et al. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 1999; 21:84.</a></li><li><a class="nounderline abstract_t">Sterkers O, Saumon G, Tran Ba Huy P, et al. Electrochemical heterogeneity of the cochlear endolymph: effect of acetazolamide. Am J Physiol 1984; 246:F47.</a></li><li><a class="nounderline abstract_t">Herak-Kramberger CM, Breton S, Brown D, et al. Distribution of the vacuolar H+ atpase along the rat and human male reproductive tract. Biol Reprod 2001; 64:1699.</a></li><li><a class="nounderline abstract_t">Joshua B, Kaplan DM, Raveh E, et al. Audiometric and imaging characteristics of distal renal tubular acidosis and deafness. J Laryngol Otol 2008; 122:193.</a></li><li><a class="nounderline abstract_t">Enerbäck S, Nilsson D, Edwards N, et al. Acidosis and Deafness in Patients with Recessive Mutations in FOXI1. J Am Soc Nephrol 2018; 29:1041.</a></li><li><a class="nounderline abstract_t">Karet FE, Finberg KE, Nayir A, et al. Localization of a gene for autosomal recessive distal renal tubular acidosis with normal hearing (rdRTA2) to 7q33-34. Am J Hum Genet 1999; 65:1656.</a></li><li><a class="nounderline abstract_t">Stover EH, Borthwick KJ, Bavalia C, et al. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet 2002; 39:796.</a></li><li><a class="nounderline abstract_t">Tanphaichitr VS, Sumboonnanonda A, Ideguchi H, et al. Novel AE1 mutations in recessive distal renal tubular acidosis. Loss-of-function is rescued by glycophorin A. J Clin Invest 1998; 102:2173.</a></li><li><a class="nounderline abstract_t">Rungroj N, Nettuwakul C, Sawasdee N, et al. Distal renal tubular acidosis caused by tryptophan-aspartate repeat domain 72 (WDR72) mutations. Clin Genet 2018; 94:409.</a></li><li><a class="nounderline abstract_t">Pessler F, Emery H, Dai L, et al. The spectrum of renal tubular acidosis in paediatric Sjögren syndrome. Rheumatology (Oxford) 2006; 45:85.</a></li><li><a class="nounderline abstract_t">Hataya H, Ikeda M, Ide Y, et al. Distal tubular dysfunction in lupus nephritis of childhood and adolescence. Pediatr Nephrol 1999; 13:846.</a></li><li><a class="nounderline abstract_t">Bagga A, Jain Y, Srivastava RN, Bhuyan UN. Renal tubular acidosis preceding systemic lupus erythematosus. Pediatr Nephrol 1993; 7:735.</a></li><li><a class="nounderline abstract_t">Batlle D, Ghanekar H, Jain S, Mitra A. Hereditary distal renal tubular acidosis: new understandings. Annu Rev Med 2001; 52:471.</a></li><li><a class="nounderline abstract_t">Gómez-Conde S, García-Castaño A, Aguirre M, et al. Molecular aspects and long-term outcome of patients with primary distal renal tubular acidosis. Pediatr Nephrol 2021; 36:3133.</a></li><li><a class="nounderline abstract_t">Rodríguez-Soriano J. New insights into the pathogenesis of renal tubular acidosis--from functional to molecular studies. Pediatr Nephrol 2000; 14:1121.</a></li><li><a class="nounderline abstract_t">Nash MA, Torrado AD, Greifer I, et al. Renal tubular acidosis in infants and children. Clinical course, response to treatment, and prognosis. J Pediatr 1972; 80:738.</a></li><li><a class="nounderline abstract_t">Rodriguez Soriano J, Boichis H, Stark H, Edelmann CM Jr. Proximal renal tubular acidosis. A defect in bicarbonate reabsorption with normal urinary acidification. Pediatr Res 1967; 1:81.</a></li><li><a class="nounderline abstract_t">Donckerwolcke RA, van Stekelenburg GJ, Tiddens HA. A case of bicarbonate-losing renal tubular acidosis with defective carboanhydrase activity. Arch Dis Child 1970; 45:769.</a></li><li><a class="nounderline abstract_t">Igarashi T, Inatomi J, Sekine T, et al. Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet 1999; 23:264.</a></li><li><a class="nounderline abstract_t">Jentsch TJ, Keller SK, Koch M, Wiederholt M. Evidence for coupled transport of bicarbonate and sodium in cultured bovine corneal endothelial cells. J Membr Biol 1984; 81:189.</a></li><li><a class="nounderline abstract_t">Igarashi T, Inatomi J, Sekine T, et al. Novel nonsense mutation in the Na+/HCO3- cotransporter gene (SLC4A4) in a patient with permanent isolated proximal renal tubular acidosis and bilateral glaucoma. J Am Soc Nephrol 2001; 12:713.</a></li><li><a class="nounderline abstract_t">Winsnes A, Monn E, Stokke O, Feyling T. Congenital persistent proximal type renal tubular acidosis in two brothers. Acta Paediatr Scand 1979; 68:861.</a></li><li><a class="nounderline abstract_t">Igarashi T, Ishii T, Watanabe K, et al. Persistent isolated proximal renal tubular acidosis--a systemic disease with a distinct clinical entity. Pediatr Nephrol 1994; 8:70.</a></li><li><a class="nounderline abstract_t">Brenes LG, Brenes JN, Hernandez MM. Familial proximal renal tubular acidosis. A distinct clinical entity. Am J Med 1977; 63:244.</a></li><li><a class="nounderline abstract_t">Katzir Z, Dinour D, Reznik-Wolf H, et al. Familial pure proximal renal tubular acidosis--a clinical and genetic study. Nephrol Dial Transplant 2008; 23:1211.</a></li><li><a class="nounderline abstract_t">Wang T, Yang CL, Abbiati T, et al. Mechanism of proximal tubule bicarbonate absorption in NHE3 null mice. Am J Physiol 1999; 277:F298.</a></li><li><a class="nounderline abstract_t">Knights MJ, Finlay E. The effects of sodium valproate on the renal function of children with epilepsy. Pediatr Nephrol 2014; 29:1131.</a></li><li><a class="nounderline abstract_t">Hall AM, Bass P, Unwin RJ. Drug-induced renal Fanconi syndrome. QJM 2014; 107:261.</a></li><li><a class="nounderline abstract_t">Chuang GT, Tsai IJ, Tsau YK, Lu MY. Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use. Nephrology (Carlton) 2015; 20:931.</a></li><li class="breakAll">Foreman, JW. Fanconi syndrome and cystinosis. In: Pediatric Nephrology, 3rd ed, Holliday, MA, Barratt, TM, Avner, ED (Eds), Williams &amp; Wilkins, Philadelphia 1994. p.537.</li><li><a class="nounderline abstract_t">Tashian RE. Genetics of the mammalian carbonic anhydrases. Adv Genet 1992; 30:321.</a></li><li><a class="nounderline abstract_t">Sly WS, Hewett-Emmett D, Whyte MP, et al. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci U S A 1983; 80:2752.</a></li><li><a class="nounderline abstract_t">Whyte MP, Murphy WA, Fallon MD, et al. Osteopetrosis, renal tubular acidosis and basal ganglia calcification in three sisters. Am J Med 1980; 69:64.</a></li><li><a class="nounderline abstract_t">Roth DE, Venta PJ, Tashian RE, Sly WS. Molecular basis of human carbonic anhydrase II deficiency. Proc Natl Acad Sci U S A 1992; 89:1804.</a></li><li><a class="nounderline abstract_t">Pereira PC, Miranda DM, Oliveira EA, Silva AC. Molecular pathophysiology of renal tubular acidosis. Curr Genomics 2009; 10:51.</a></li><li><a class="nounderline abstract_t">Batlle DC, Arruda JA, Kurtzman NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med 1981; 304:373.</a></li></ol></div><div id="topicVersionRevision">Topic 6121 Version 34.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28188436" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Clinical and molecular aspects of distal renal tubular acidosis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28233610" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30773598" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Treatment and long-term outcome in primary distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9312167" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9497368" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3- exchanger.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9600966" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1301935" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A splice junction mutation in intron 2 of the carbonic anhydrase II gene of osteopetrosis patients from Arabic countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29725771" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Distal renal tubular acidosis. Clinical manifestations in patients with different underlying gene mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4296662" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : [Enzymatic anomalies and human nephropathies].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9916796" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6696078" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Electrochemical heterogeneity of the cochlear endolymph: effect of acetazolamide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11369598" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Distribution of the vacuolar H+ atpase along the rat and human male reproductive tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17669226" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Audiometric and imaging characteristics of distal renal tubular acidosis and deafness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29242249" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Acidosis and Deafness in Patients with Recessive Mutations in FOXI1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10577919" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Localization of a gene for autosomal recessive distal renal tubular acidosis with normal hearing (rdRTA2) to 7q33-34.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12414817" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9854053" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Novel AE1 mutations in recessive distal renal tubular acidosis. Loss-of-function is rescued by glycophorin A.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30028003" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Distal renal tubular acidosis caused by tryptophan-aspartate repeat domain 72 (WDR72) mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16159947" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The spectrum of renal tubular acidosis in paediatric Sjögren syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10603134" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Distal tubular dysfunction in lupus nephritis of childhood and adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7510511" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Renal tubular acidosis preceding systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11160790" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Hereditary distal renal tubular acidosis: new understandings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33881640" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Molecular aspects and long-term outcome of patients with primary distal renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11045400" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : New insights into the pathogenesis of renal tubular acidosis--from functional to molecular studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5018384" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Renal tubular acidosis in infants and children. Clinical course, response to treatment, and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6029811" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Proximal renal tubular acidosis. A defect in bicarbonate reabsorption with normal urinary acidification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4992595" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A case of bicarbonate-losing renal tubular acidosis with defective carboanhydrase activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10545938" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6502693" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Evidence for coupled transport of bicarbonate and sodium in cultured bovine corneal endothelial cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11274232" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Novel nonsense mutation in the Na+/HCO3- cotransporter gene (SLC4A4) in a patient with permanent isolated proximal renal tubular acidosis and bilateral glaucoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/44068" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Congenital persistent proximal type renal tubular acidosis in two brothers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8142230" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Persistent isolated proximal renal tubular acidosis--a systemic disease with a distinct clinical entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/888846" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Familial proximal renal tubular acidosis. A distinct clinical entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17881426" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Familial pure proximal renal tubular acidosis--a clinical and genetic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10444585" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Mechanism of proximal tubule bicarbonate absorption in NHE3 null mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23720013" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The effects of sodium valproate on the renal function of children with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24368854" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Drug-induced renal Fanconi syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26016559" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26016559" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1456113" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Genetics of the mammalian carbonic anhydrases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6405388" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7386510" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Osteopetrosis, renal tubular acidosis and basal ganglia calcification in three sisters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1542674" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Molecular basis of human carbonic anhydrase II deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19721811" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Molecular pathophysiology of renal tubular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7453754" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
